Compare BioNTech SE - ADR (BNTX) vs Rigetti Computing Inc (RGTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Rigetti Computing Inc — how do they compare? BioNTech SE - ADR trades at $90.35 (market cap $22.86B), while Rigetti Computing Inc trades at $15.17 (market cap $5.35B). The key difference: BioNTech SE - ADR is far larger — about 4.3× Rigetti Computing Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Rigetti Computing Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | RGTI | |
|---|---|---|
Market Cap | $22.86B | $5.35B |
Sector | Health | Technology |
52-Week High | $119.34 | $56.34 |
52-Week Low | $83.89 | $12.72 |
Enterprise Value | $6.53B | $4.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rigetti Computing (RGTI) trades at $15.36, down 7.13% in the last 24 hours, with a bearish technical signal but bullish oscillators. The company reported a net loss of $216.21 million in 2025, with a negative net income margin of -2,253.59%, while revenue grew to $7.09 million. Recent news highlights quantum computing interest following Quantinuum's IPO and Rigetti's infrastructure developments, including the Fab-1 facility and a 108-qubit contract.
Despite significant losses and cash burn, analyst consensus is strongly bullish with an 85.71% buy rating and a $32.67 price target, suggesting over 112% upside. Key risks include high cash burn rates, intense competition, and the long timeline to quantum advantage, requiring careful risk assessment for speculative investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Rigetti Computing Inc
Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →
